4//SEC Filing
Schilke Tobin 4
Accession 0001479290-24-000103
CIK 0001479290other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 5:47 PM ET
Size
4.9 KB
Accession
0001479290-24-000103
Insider Transaction Report
Form 4
Transactions
- Award
Common Stock
2024-06-30$2.18/sh+1,000$2,185→ 193,666 total
Footnotes (1)
- [F1]These shares were acquired by Mr. Schilke under the Issuer's 2014 Employee Stock Purchase Plan on June 30, 2024 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001678984
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 5:47 PM ET
- Size
- 4.9 KB